J.W. Cole Advisors, Inc. Aim Immuno Tech Inc. Transaction History
J.W. Cole Advisors, Inc.
- $3.14 Billion
- Q1 2025
A detailed history of J.W. Cole Advisors, Inc. transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 15,000 shares of AIM stock, worth $1,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$1,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AIM
# of Institutions
37Shares Held
4.83MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.44MShares$195,5450.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$55,8610.0% of portfolio
-
Geode Capital Management, LLC Boston, MA531KShares$42,5060.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny318KShares$25,4380.0% of portfolio
-
State Street Corp Boston, MA173KShares$13,8480.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $3.84M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...